ENDOLUMINAL GASTROPLICATION FOR ENDOSCOPIC TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) TO BE DEMONSTRATED AT BRIGHAM & WOMEN'S HOSPITAL
WEDNESDAY, MAY 7TH AT 4:00PM EDT
April 28, 2003 --
Boston, MA. - March 25, 2003 - Dr. David Carr-Locke at Brigham & Women's Hospital with Dr. Richard Rothstein of Dartmouth-Hitchcock Medical Center will endoscopically treat a patient with Gastroesophageal Reflux Disease using The Bard® EndoCinch™ device. The live webcast of the procedure will take place on Wednesday, May 7th at 4PM EST. Health care professionals and patients will have the ability to observe a live procedure as well as e-mail questions directly to the presenting physicians during the webcast.
What is Endoluminal Gastroplication?
Endoluminal Gastroplication is a medical therapy developed for the treatment of symptomatic Gastroesophageal Reflux Disease (GERD). The procedure works by creating plications, or pleats, at the lower esophageal sphincter (LES). Performing the procedure has been shown to significantly improve symptoms and regurgitation while reducing or eliminating patients' dependence on acid-controlling medications.
How is the procedure performed?
The EndoCinch System, like a tiny sewing machine, is attached to the end of a standard, flexible endoscope or tube, which allows the physician to place suture (stitch) near the LES. Two stitches can be placed and tied together to create a pleat near the LES and treat symptomatic reflux or acid reflux.
Where is the procedure performed?
The procedure is typically performed in the hospital or surgical center, on an outpatient basis, so that patients can return home the same day. Typically, only mild sedation is required (no general anesthesia) and patients can return to normal activities the next day.
About C. R. Bard, Inc.
C. R. Bard, Inc., headquartered in Murray Hill, New Jersey, is a leading multinational developer, manufacturer and marketer of healthcare products. Bard Endoscopic Technologies, headquartered in Billerica, MA, is a division of C. R. Bard, Inc. (NYSE-BCR), specializing in the field of gastroenterology. For more than ten years, Bard Endoscopic Technologies (formerly Bard Interventional Products) has been developing minimally invasive diagnostic and therapeutic products used in conjunction with procedures requiring flexible endoscopy. Visit the company website at www.crbard.com.
Find a Physician
